Evidence map›Paper›PMID 19223639›Full record

ArticleAntimicrobial agents and chemotherapy2009

Novel imino sugar derivatives demonstrate potent antiviral activity against flaviviruses.

Jinhong Chang, Lijuan Wang, Dongling Ma, Xiaowang Qu, Haitao Guo, Xiaodong Xu, Peter M Mason, Nigel Bourne, Robert Moriarty, Baohua Gu and 2 more

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Mechanisms of Antiviral Activity of Iminosugars Against Dengue Virus.Advances in experimental medicine and biology · 2018
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. A novel rare sugar inhibitor of murine herpes simplex keratitis.Journal of pharmacological sciences · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jinhong ChangDepartment of Microbiology and Immunology, Drexel Institute for Biotechnology and Virology Research, Drexel University College of Medicine, Doylestown, Pennsylvania 18902, USA. jinhong.chang@drexelmed.edu
Lijuan Wang
Dongling Ma
Xiaowang Qu
Haitao Guo
Xiaodong Xu
Peter M Mason
Nigel Bourne
Robert Moriarty
Baohua Gu
Ju-Tao Guo
Timothy M Block

Funding

Imino sugars for flavivirus infections of bioterrorU01AI061441 · NIAID · DREXEL UNIVERSITY · PI BLOCK, TIMOTHY M · 2005 to 2010
$7.8M
NIAID NIH HHS AI061441NIAID NIH HHS U01 AI061441
6 · The paper itself

Abstract

Imino sugars, such as N-butyl-deoxynojirimycin and N-nonyl-deoxynojirimycin (NNDNJ), are glucose analogues that selectively inhibit cellular alpha-glucosidase I and II in the endoplasmic reticulum and exhibit antiviral activities against many types of enveloped viruses. Although these molecules have broad-spectrum antiviral activity, their development has been limited by a lack of efficacy and/or selectivity. We have previously reported that a DNJ derivative with a hydroxylated cyclohexyl side chain, called OSL-95II, has an antiviral efficacy similar to that of NNDNJ but significantly less toxicity. Building upon this observation, a family of imino sugar derivatives containing an oxygenated side chain and terminally restricted ring structures were synthesized and shown to have low cytotoxicity and superior antiviral activity against members of the Flaviviridae family, including bovine viral diarrhea virus, dengue virus (DENV), and West Nile virus. Of particular interest is that several of these novel imino sugar derivatives, such as PBDNJ0801, PBDNJ0803, and PBDNJ0804, potently inhibit DENV infection in vitro, with 90% effective concentration values at submicromolar concentrations and selectivity indices greater than 800. Therefore, these compounds represent the best in their class and may offer realistic candidates for the development of antiviral therapeutics against human DENV infections.

Indexed as

Glycoside Hydrolase Inhibitors1-DeoxynojirimycinAnimalsAntiviral AgentsCattleCell LineCricetinaeFlavivirusImino SugarsStructure-Activity Relationship1-DeoxynojirimycinAntiviral AgentsGlycoside Hydrolase InhibitorsImino SugarsN-nonyl-1-deoxynojirimycin

Identifiers

PMID19223639
PMCPMC2663077

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.